Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using a Diagnostic Taste Test as a Surrogate Biomarker to Predict Drug Effectiveness in Patients With Depression (MDD)

NCT03645447 is registered in ClinicalTrials.gov with Ranvier Health Ltd as lead sponsor.

NCT NCT03645447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03645447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using a Diagnostic Taste Test as a Surrogate Biomarker to Predict Drug Effectiveness in Patients With Depression (MDD)
Lead sponsor
Ranvier Health Ltd
Phase
Not applicable
Overall status
Suspended
Start date
June 6, 2022
Completion date
February 28, 2027
Enrollment
240 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

depression